alantolactone has been researched along with Colorectal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Li, X; Liu, Y; Shen, L; Song, W; Zhang, J | 1 |
| Cao, P; Cui, R; He, W; Hong, L; Liang, G; Shen, X; Xia, Y; Zhang, T; Zheng, P; Zou, P | 1 |
| Cheng, Y; Ding, Y; Gou, Y; Luo, M; Miao, L; Niu, J; Wang, H; Zou, Z | 1 |
3 other study(ies) available for alantolactone and Colorectal Neoplasms
| Article | Year |
|---|---|
Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Colorectal Neoplasms; Drug Delivery Systems; Drug Synergism; Female; Lactones; Mice; Mice, Inbred BALB C; Micelles; Microsatellite Repeats; Nanoparticles; Quercetin; Sesquiterpenes, Eudesmane; Tumor Microenvironment | 2019 |
Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Colorectal Neoplasms; HCT116 Cells; Humans; Lactones; MAP Kinase Signaling System; Oxaliplatin; Reactive Oxygen Species; Sesquiterpenes, Eudesmane | 2019 |
Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Colon; Colorectal Neoplasms; DNA Damage; Guanine; Humans; Inula; Lactones; Oxidative Stress; Reactive Oxygen Species; Rectum; Sesquiterpenes, Eudesmane | 2016 |